|
|
|
|
Cell Movements Totally Modular, Stanford Study Shows
A study describing how cells within blood vessel walls move en masse overturns an assumption common in the age of genomics - that the proteins driving cell behavior are doing so much multitasking that it would be near impossible to group...
|
|
|
Cell movements totally modular, Stanford study shows
- A study describing how cells within blood vessel walls move en masse overturns an assumption common in the age of genomics that the proteins driving cell behavior are doing so much multitasking that it would be near impossible to group...
|
|
|
Cell Movements Totally Modular, Stanford Study Shows
But now researchers at the Stanford University School of Medicine have shown that distinct groups of proteins each control one of four simple activities involved in the cells' collective migration.The findings will be published in the Dec...
|
|
|
Multitasking proteins driving cell behavior
Medical Research News A study describing how cells within blood vessel walls move en masse overturns an assumption common in the age of genomics - that the proteins driving cell behavior are doing so much multitasking that it would be near...
|
|
|
Wyeth, Progenics report positive results from phase III study of Relistor
Wyeth Pharmaceuticals, a division of Wyeth, and Progenics Pharmaceuticals, Inc.said their phase III clinical study investigating Relistor (methylnaltrexone bromide) subcutaneous injection to treat opioid-induced constipation (OIC) in...
|
|
|
Winfrey helps honor Taylor of Essence
Susan L.Taylor, editor-in-chief of Essence magazine, will be honored in part by famed TV host Oprah Winfrey at a New York event, a press group says. A Noerdlinger Media press release Saturday said Taylor's 37 years with the magazine for...
|
|
|
Proteins That Assist Fracture Healing Causing Abnormal Bone Growth In Soft Tissues
A report published today in The Journal of Bone and Joint Surgery, British Volume details four case studies where proteins used to augment bone formation in applications such as, healing of nonunion, may play a role in the development of...
|
|
|
Assam bird flu due to migratory birds: Ramadoss
Chennai, Nov 29 - Migratory birds are behind the fresh outbreak of bird flu in Assam, Indian Health Minister Anbumani Ramadoss said Saturday, adding that culling operations had started in the northeastern state and 'inter-country bird ...
|
|
|
Phase 3 Study Of Subcutaneous Relistor For Opioid-Induced Constipation For Chronic Non-Cancer Pain
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc.(Nasdaq: PGNX) announced today that a phase 3 clinical study investigating RELISTOR (methylnaltrexone bromide) subcutaneous injection to treat...
|
|
|
Mme Roberta Bondar, Ph. D., championne nationale de la biotechnologie au
A Canadian woman freed from a Mumbai hotel that was stormed by armed gunmen as part of a bloody and coordinated rampage that left over 130 dead said she was 'fine' and on her way to the airport following a 36 hour siege finally broken by...
|
|
|
Dr. Roberta Bondar, CanadaEURs National Biotechnology Champion, Speaks about
A Canadian woman freed from a Mumbai hotel that was stormed by armed gunmen as part of a bloody and coordinated rampage that left over 130 dead said she was 'fine' and on her way to the airport following a 36 hour siege finally broken by...
|
|
|
Wyeth and Progenics report positive results from Phase III study of Relistor
Adverse events observed in this study were similar to those seen in prior studies of subcutaneous Relistor.The positive outcome reported was from the double-blind, randomized placebo-controlled portion of a Phase III clinical study. In...
|
|
|
FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC - Preliminary Announcement
(PR Newswire Europe via COMTEX) -- FWPTF | Quote | Chart | News | PowerRating -- NEWS RELEASE 28 November 2008 FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC Unaudited Preliminary Results for the six months ended 30 September 2008 Finsbury...
|
|
|
Wyeth and Progenics report positive results from Phase III study of Relistor
(Datamonitor via COMTEX) -- WYE | Quote | Chart | News | PowerRating -- Wyeth Pharmaceuticals, a division of Wyeth, and Progenics Pharmaceuticals, a biopharmaceutical company, have announced that a Phase III clinical study investigating...
|
|
|
Sleep-related Movement Disorders Linked to Relapsing-remitting MS
Fifty-four percent of relapsing-remitting MS patients with sleep disorders also had a sleep-related movement disorder, according to a new study.SALT LAKE CITY-People with multiple sclerosis (MS) have trouble with sleep. Now,...
|
|
|
Why Research Supports the Practice (of a Placebo Effect)
Several investigators interviewed by Neurology Today said new research has identified brain mechanisms that enable the placebo effect to produce significant relief, especially for certain neurologically mediated disorders.Nico J.
|
|
|
Discovery may lead to new therapeutic approaches for pain reduction
Medical Research News By manipulating the appearance of a chronically achy hand, researchers have found they could increase or decrease the pain and swelling in patients moving their symptomatic limbs.The findings - reported in the...
|
|
|
Wyeth and Progenics Announce Positive Outcome of Phase 3 Clinical Study of Subcutaneous RELISTOR for Opioid-In
- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc.(Nasdaq: PGNX) announced today that a phase 3 clinical study investigating RELISTOR (methylnaltrexone bromide) subcutaneous injection to treat...
|
|
|
Wyeth and Progenics Announce Positive Outcome of Phase 3 Clinical Study of Subcutaneous RELISTOR for Opioid-In
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc.(Nasdaq: PGNX) announced today that a phase 3 clinical study investigating RELISTOR (methylnaltrexone bromide) subcutaneous injection to treat...
|
|
|
Wyeth and Progenics Announce Positive Outcome of Phase 3 Clinical Study of Subcutaneous RELISTOR for Opioid-In
rmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc.(Nasdaq: PGNX | Quote | Chart | News | PowerRating) announced today that a phase 3 clinical study investigating RELISTOR(R) (methylnaltrexone bromide)...
|
|
|
How Proteins Bind With DNA
Biochemists at North Carolina State University have answered a fundamental question of how important bacterial proteins make life-and-death decisions that allow them to function, a finding that could provide a new target for drugs to disrupt...
|
|
|
Ovation Pharmaceuticals Announces Nationwide Availability of Xenazine (tetrabenazine) Tablets in U.S. for Chor
- OVATION Pharmaceuticals, Inc.announced today that Xenazine* (tetrabenazine) Tablets, an orphan drug recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of chorea associated with Huntington's disease (HD)...
|
|
|
Scientists present 'moving' theory behind bacterial decision-making
Medical Research News Biochemists at North Carolina State University have answered a fundamental question of how important bacterial proteins make life-and-death decisions that allow them to function, a finding that could provide a new...
|
|
|
HST Global Quarterly Update
The growing acceptance of alternative cancer treatments worldwide has placed HST Global in perfect position to launch a wholly owned division dedicated to opening our own brand of Cancer Treatment Centers.While we continue to look for in...
|
|
|
Ovation Pharmaceuticals Announces Nationwide Availability of Xenazine* (tetrabenazine) Tablets in U.S. for Cho
- OVATION Pharmaceuticals, Inc.announced today that Xenazine* (tetrabenazine) Tablets, an orphan drug recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of chorea associated with Huntingtons disease (HD),...
|
